186 related articles for article (PubMed ID: 33793366)
1. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
[No Abstract] [Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
[TBL] [Abstract][Full Text] [Related]
3. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
Konishi M
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
Nakachi K; Gotohda N; Hatano E; Nara S; Takahashi S; Kawamoto Y; Ueno M
Jpn J Clin Oncol; 2023 Nov; 53(11):1019-1026. PubMed ID: 37599063
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059
[No Abstract] [Full Text] [Related]
7. Adjuvant treatment in biliary tract cancer: to treat or not to treat?
Cereda S; Belli C; Reni M
World J Gastroenterol; 2012 Jun; 18(21):2591-6. PubMed ID: 22690066
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
[TBL] [Abstract][Full Text] [Related]
9. Biliary tract: Is there a role for neoadjuvant and adjuvant therapy in biliary cancer?
Jarnagin WR
Nat Rev Gastroenterol Hepatol; 2012 Nov; 9(11):622-3. PubMed ID: 23007479
[No Abstract] [Full Text] [Related]
10. Adjuvant therapy for resected biliary tract cancer: a review.
Doherty MK; Knox JJ
Chin Clin Oncol; 2016 Oct; 5(5):64. PubMed ID: 27701873
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant treatments for biliary tract cancer.
Furuse J
J Hepatobiliary Pancreat Surg; 2008; 15(5):463-7. PubMed ID: 18836797
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy trials in biliary tract malignancies.
Medin CR; Maithel SK
J Surg Oncol; 2022 Jan; 125(1):84-88. PubMed ID: 34897705
[No Abstract] [Full Text] [Related]
13. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
Nakachi K; Konishi M; Ikeda M; Shimada K; Okusaka T; Saiura A; Ishii H; Sugiyama M; Furuse J; Sakamoto H; Shimamura T; Ohta T
Int J Clin Oncol; 2018 Oct; 23(5):894-899. PubMed ID: 29705976
[TBL] [Abstract][Full Text] [Related]
14. Current therapy and future directions in biliary tract malignancies.
Ciombor KK; Goff LW
Curr Treat Options Oncol; 2013 Sep; 14(3):337-49. PubMed ID: 23686724
[TBL] [Abstract][Full Text] [Related]
15. Multimodality Management of Localized Biliary Cancer.
Ashai N; Prasad P; Rajdev L
Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
[TBL] [Abstract][Full Text] [Related]
16. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Kim H; Heo MH; Kim JY
BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
[TBL] [Abstract][Full Text] [Related]
18. [Current status of adjuvant therapy for biliary tract cancer].
Kato A; Miyazaki M
Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
